Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1451–1500 of 33040
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Dr. Deborah Knobelman resigned from her position as an officer of the Company.
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
On June 16, 2025, in conversations with representatives of the Board of Directors (the “Board”) of Quantum Computing Inc. (the “Company”) Mr. Christopher Boehmler indicated that he would step down as the Company’s Chief Financial Officer (the “CFO Retirement”) effective June 19, 2025
On June 20, 2025, the Board of Directors of Society Pass Incorporated (the “Company”) accepted the resignation of Mr. Howie Ng Kar How (“Mr. Ng”) as the Group Chief Technology Officer (“CTO”).
Christopher Greenberg submitted his resignation as a director and Chairman of the Board of Birchtech Corp. (the “Company”), effective July 1, 2025.
On 18 June 2025, Jeff LeBlanc, an independent director of Cactus Acquisition Corp. 1 Limited (the “Company”), notified the Company that he has resigned from the Company’s Board of Directors (the “Board”), effective immediately.
On June 19, 2025, Martyn Buttenshaw resigned as a member of the board of directors of the Company.
On June 16, 2025, John Lorbiecki notified Aclarion, Inc. of his intention to retire from his position as the Company’s Chief Financial Officer.
On June 17, 2025, Mike Dickerson, the Chief Financial Officer of Twin Vee PowerCats Co. (the “Company”), notified the Company of his decision to resign, effective September 14, 2025, from his position as the Company’s Chief Financial Officer.
On June 16, 2025, Ardent Health, Inc. (the “Company”) and David Schultz determined that Mr. Schultz would no longer serve as President, Hospital Operations and would depart the Company effective immediately.
the majority shareholder Lawrence Garcia of AmeriGuard Security Services, Inc., followed Section 3.6 of the bylaws, Resignations and Removals of Directors, removed Douglas Anderson and Russel Honore as board members.
the majority shareholder Lawrence Garcia of AmeriGuard Security Services, Inc., followed Section 3.6 of the bylaws, Resignations and Removals of Directors, removed Douglas Anderson and Russel Honore as board members.
the Board of Directors of AmeriGuard Security Services, Inc., removed Douglas Anderson, from the position of Interim Chief Executive Officer of the Company, effective immediately.
On June 17, 2025, Rebecca A. Hoyt, senior vice president, Chief Accounting Officer, and Controller, informed APA Corporation (the “Company”) of her intention to retire from the Company.
On June 12, 2025, Commonwealth Edison Company (ComEd) announced that Lewis Binswanger, Senior Vice President, Government, Regulatory, and External Affairs, will depart ComEd effective January 1, 2026.
On June 17, 2025, Fran Horowitz informed Conagra Brands, Inc. (the “Company”) that she has decided not to stand for reelection to the Board of Directors at the Company’s 2025 Annual Meeting of Shareholders to be held in September.
On June 13, 2025, Cathleen Benko notified NIKE, Inc. (the “Company”) of her decision to retire as a member of the Board of Directors of the Company (the “Board”) effective as of the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”).
Brett M. Icahn and Christian A. Garcia resigned from the board of directors
Brett M. Icahn and Christian A. Garcia resigned from the board of directors
On June 16, 2025, Carol Ashe notified the Board of Directors (the “Board”) of Aptose Biosciences Inc. (the “Company”) of her intention to resign from her role as a member of the Board effective immediately.
In addition, on June 16, 2025, Gregory A. Trojan, the Company’s former Chief Executive Officer, informed the Board that he would be retiring from the Board effective September 16, 2025.
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
On June 18, 2025, Barbara Weber, M.D., communicated her decision to resign from the board of directors (the “Board”) of Revolution Medicines, Inc.
As previously disclosed by the Company, Ms. DeCarolis has determined to retire from employment with the Company on July 1, 2025 (the “Retirement Date”).
Robert B. Klein announced his intention to resign from his role as Chief Financial Officer of Postal Realty Trust, Inc. (the “Company”) in order to accept a position with a privately-held real estate company.
Resignation of Jay Goodman
Danny L. Titus and Thomas A. Haidlen have retired as directors of Oak Valley Bancorp (the “ Company ”) and of its wholly owned subsidiary Oak Valley Community Bank effective June 17, 2025.
Thomas A. Haidlen have retired as directors of Oak Valley Bancorp (the “ Company ”) and of its wholly owned subsidiary Oak Valley Community Bank effective June 17, 2025.
On June 17, 2025, the Board of the General Partner of the Partnership and Carrie Clark, Senior Vice President and Chief Commercial Officer of the General Partner, agreed that Ms. Clark would depart her current roles at the general partner effective June 17, 2025.
On June 12, 2025, Warren Andrew Thomson resigned from the board of directors (the “Board”) of Connexa Sports Technologies Inc. (the “Company”) and all committees thereof, effective immediately.
David Feinberg will cease serving as AEP’s executive vice president and general counsel, effective July 13, 2025.
On June 12, 2025, William C. Geary, II, Executive Vice President and General Manager, Communications & Security Solutions, notified WESCO International, Inc. (the “Company”) that he is resigning from the Company to accept another position.
Riccardo Perfetti, M.D., Ph.D., departed his role as Chief Medical Officer, effective as of June 15, 2025.
On June 13, 2025, Dr. Fairooz Kabbinavar and Cardiff Oncology, Inc. (the “Company”) agreed that he would be stepping down from his position as Chief Medical Officer.
David Gibbs, who, in March 2025, informed the Board of Directors of his intention to retire in the next year after 37 years with the Company and a successful tenure as CEO.
David Harvey, the Company’s Chief Commercial Officer, will depart from his position with the Company effective June 19, 2025, but will continue to act as a senior advisor to the Company through August 2025.
On June 17, 2025, RE/MAX Holdings, Inc. (the “Company”) announced that W. Grady Ligon, the Company’s Chief Information Officer, will be leaving the Company to pursue other opportunities closer to his home.
Effective June 16, 2025, Bank First Corporation director Laura E. Kohler retired from the Board of Directors (the “Board”).
On June 16, 2025, Dr. James A. Hayward informed Applied DNA Sciences, Inc. (the “Company”) of his intention to retire from the Company and that he will step down from his positions as Chief Executive Officer, member of the Company’s board of directors (the “Board”) and Chairman of the Board effective June 18, 2025.
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.